The marketing authorization for the vaccine, Vaxzevria, in the European Union was withdrawn at the company’s request this week as the vaccine is no longer manufactured or supplied, Astra said in a statement. The decision was not related to safety reasons, it said.
Astra’s vaccine, which was developed with Oxford University, was initially offered on a not-for-profit basis and was seen as a win for Britain, ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.